biologics

Treatment of Hidradenitis Suppurativa in 2021 & Beyond
Treatment of Hidradenitis Suppurativa
by Blair Allais, MD on
At the ODAC 2021 Sneak Peek Symposium on Inflammatory Skin Diseases, expert faculty presented on the topics of acne, rosacea, atopic dermatitis, hidradenitis suppurativa, and psoriasis. If you missed the live symposium, Next Steps will be sharing highlights and a summary of each lecture over the course of the next few weeks. Today, Dr. Blari Allais shares an excellent recap of Dr. Joslyn Kirby's s …
COVID-19 News & Resource Center
COVID-19 News & Resources
by NEXT STEPS IN DERM TEAM on
EPI Health has graciously supported the COVID-19 News and Resource Center. COVID-19 DERM TOPICS Safely Reopening Derm Practices Video Series JDD COVID-19 Webinar Series COVID-19: Urgent Medical and Aesthetic Issues for Dermatology Streamed live on April 1st, 2020, and now available to watch on-demand, this webinar panel provides discussion, guidance, and leadership for dermatologists and …
Tumor Necrosis Factor (TNF) Inhibitors Therapeutic Cheat Sheet
TNF inhibitors for psoriasis
by Jessica Kalen, MD on
With the advent of biologics, patients with moderate-to-severe plaque psoriasis have experienced increased control of disease and improved quality of life. Tumor necrosis factor (TNF) inhibitors are some of the earliest biologics prescribed for psoriasis, psoriatic arthritis and, more recently, hidradenitis suppurativa. In this month’s installment of Therapeutic Cheat Sheets, we discuss TNF inhi …
Methotrexate Therapeutic Cheat Sheet
Methotrexate injection for psoriasis
by Jessica Kalen, MD on
In this month’s installment of Therapeutic Cheat Sheet, we will review methotrexate and its use in dermatology. Methotrexate has been utilized as therapy for psoriasis and many other dermatologic conditions since its approval by the FDA in 1972.1 While an effective systemic agent for a multitude of dermatologic and non-dermatologic diseases, prescribers should be aware of the side effect profile …
Inhibiting the JAK/STAT Pathway to Treat Inflammatory Skin Diseases
JAK Inhibitors
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Jonathan Zippin, Vice-Chair of Research and an Associate Attending Dermatologist and Associate Professor of Dermatology at Weill Medical College of Cornell, and Director of the Contact, Occupational and Photodermatitis Service. Watch as he reviews the JAK/STAT signaling pathway in normal i …